DNLI - Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04 revenue of $52.48M beats by $7.82M
- Denali Therapeutics press release ( NASDAQ: DNLI ): Q2 GAAP EPS of -$0.48 beats by $0.04 .
- Revenue of $52.48M (+128.8% Y/Y) beats by $7.82M .
For further details see:
Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04, revenue of $52.48M beats by $7.82M